Search research articles
Contact Us
Filters
Showing results (71-80 of 198) with videos related to
Page
of 20
Sort By:
Nature Communications
|
March 27, 2021
Multi-pronged neuromodulation intervention engages the residual motor circuitry to facilitate walking in a rat model of spinal cord injury
Marco Bonizzato, Nicholas D James, Galyna Pidpruzhnykova, et al.
European Urology
|
December 18, 2019
Patient-reported Quality of Life Outcomes in Patients Treated for Muscle-invasive Bladder Cancer with Radiotherapy ± Chemotherapy in the BC2001 Phase III Randomised Controlled Trial
Robert A Huddart, Emma Hall, Rebecca Lewis, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)
|
February 4, 2020
Fluid intake and clinicopathological characteristics of bladder cancer: the West Midlands Bladder Cancer Prognosis Programme
Mitch van Hensbergen, Frits H M van Osch, Sylvia Jochems, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
April 4, 2014
Large-scale chondroitin sulfate proteoglycan digestion with chondroitinase gene therapy leads to reduced pathology and modulates macrophage phenotype following spinal cord contusion injury
Katalin Bartus, Nicholas D James, Athanasios Didangelos, et al.
European Urology
|
March 24, 2025
Towards Epigenetic-based Subtyping of Bladder Cancer: DNA Methylation Predicts Molecular Subtypes of Non-muscle-invasive Bladder Cancer
Minghao Yu, Anshita Goel, Benjamin Tura, et al.
The Lancet. Oncology
|
February 4, 2021
Hypofractionated radiotherapy in locally advanced bladder cancer: an individual patient data meta-analysis of the BC2001 and BCON trials
Ananya Choudhury, Nuria Porta, Emma Hall, et al.
Biochemistry and Biophysics Reports
|
May 1, 2026
The role of HAI-1 in urothelial bladder cancer: Tissue expression, ectodomain shedding and clinical outcomes
Azad K Saeed, Panagiotis Triantafyllakis, Naheema S Gordon, et al.
The New England Journal of Medicine
|
April 20, 2012
Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer
Nicholas D James, Syed A Hussain, Emma Hall, et al.
Plos One
|
September 21, 2017
Interleukin-17-positive mast cells influence outcomes from BCG for patients with CIS: Data from a comprehensive characterisation of the immune microenvironment of urothelial bladder cancer
Alexander C Dowell, Ellen Cobby, Kaisheng Wen, et al.
Scientific Reports
|
July 28, 2018
Defining the frequency of human papillomavirus and polyomavirus infection in urothelial bladder tumours
Matthew A Llewellyn, Naheema S Gordon, Ben Abbotts, et al.
Page
of 20
Search research articles
Search
Showing results (71-80 of 198) with videos related to
Sort By:
Page
of 20
Nature Communications
|
March 27, 2021
Multi-pronged neuromodulation intervention engages the residual motor circuitry to facilitate walking in a rat model of spinal cord injury
Marco Bonizzato, Nicholas D James, Galyna Pidpruzhnykova, et al.
European Urology
|
December 18, 2019
Patient-reported Quality of Life Outcomes in Patients Treated for Muscle-invasive Bladder Cancer with Radiotherapy ± Chemotherapy in the BC2001 Phase III Randomised Controlled Trial
Robert A Huddart, Emma Hall, Rebecca Lewis, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)
|
February 4, 2020
Fluid intake and clinicopathological characteristics of bladder cancer: the West Midlands Bladder Cancer Prognosis Programme
Mitch van Hensbergen, Frits H M van Osch, Sylvia Jochems, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
April 4, 2014
Large-scale chondroitin sulfate proteoglycan digestion with chondroitinase gene therapy leads to reduced pathology and modulates macrophage phenotype following spinal cord contusion injury
Katalin Bartus, Nicholas D James, Athanasios Didangelos, et al.
European Urology
|
March 24, 2025
Towards Epigenetic-based Subtyping of Bladder Cancer: DNA Methylation Predicts Molecular Subtypes of Non-muscle-invasive Bladder Cancer
Minghao Yu, Anshita Goel, Benjamin Tura, et al.
The Lancet. Oncology
|
February 4, 2021
Hypofractionated radiotherapy in locally advanced bladder cancer: an individual patient data meta-analysis of the BC2001 and BCON trials
Ananya Choudhury, Nuria Porta, Emma Hall, et al.
Biochemistry and Biophysics Reports
|
May 1, 2026
The role of HAI-1 in urothelial bladder cancer: Tissue expression, ectodomain shedding and clinical outcomes
Azad K Saeed, Panagiotis Triantafyllakis, Naheema S Gordon, et al.
The New England Journal of Medicine
|
April 20, 2012
Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer
Nicholas D James, Syed A Hussain, Emma Hall, et al.
Plos One
|
September 21, 2017
Interleukin-17-positive mast cells influence outcomes from BCG for patients with CIS: Data from a comprehensive characterisation of the immune microenvironment of urothelial bladder cancer
Alexander C Dowell, Ellen Cobby, Kaisheng Wen, et al.
Scientific Reports
|
July 28, 2018
Defining the frequency of human papillomavirus and polyomavirus infection in urothelial bladder tumours
Matthew A Llewellyn, Naheema S Gordon, Ben Abbotts, et al.
Page
of 20